{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:26:17Z","timestamp":1774985177339,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.semarthrit.2023.152357","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:41:30Z","timestamp":1705711290000},"page":"152357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Associations of galectin-3 levels with measures of vascular disease in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"65","author":[{"given":"Amanda","family":"Nussdorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5277-349X","authenticated-orcid":false,"given":"Elizabeth","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Amigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Geraldino-Pardilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahat","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon T","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan M","family":"Bathon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2023.152357_bib0001","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/art.21560","article-title":"Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis","volume":"54","author":"Nicola","year":"2006","journal-title":"Arthrit Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152357_bib0002","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/1756-185X.14058","article-title":"Excess mortality persists in patients with rheumatoid arthritis","volume":"24","author":"Lee","year":"2021","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152357_bib0003","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1002\/art.22979","article-title":"The widening mortality gap between rheumatoid arthritis patients and the general population","volume":"56","author":"Gonzalez","year":"2007","journal-title":"Arthrit Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152357_bib0004","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.amjcard.2012.03.044","article-title":"Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"110","author":"Crowson","year":"2012","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152357_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020379","article-title":"Galectin-3: one molecule for an alphabet of diseases, from A to Z","volume":"19","author":"Sciacchitano","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152357_bib0006","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152357_bib0007","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.30118","article-title":"Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis","volume":"63","author":"Forsman","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152357_bib0008","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/art.11287","article-title":"Galectin 3 and its binding protein in rheumatoid arthritis","volume":"48","author":"Ohshima","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152357_bib0009","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/sji.12619","article-title":"Galectin-3 is persistently increased in early Rheumatoid Arthritis (RA) and associates with anti-CCP seropositivity and MRI bone lesions, while early fibrosis markers correlate with disease activity","volume":"86","author":"Issa","year":"2017","journal-title":"Scand J Immunol"},{"issue":"14","key":"10.1016\/j.semarthrit.2023.152357_bib0010","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152357_bib0011","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152357_bib0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4070\/kcj.2013.43.4.223","article-title":"Spatial and temporal expression, and statin responsiveness of galectin-1 and galectin-3 in murine atherosclerosis","volume":"43","author":"Lee","year":"2013","journal-title":"Korean Circ J"},{"key":"10.1016\/j.semarthrit.2023.152357_bib0013","series-title":"Galectin-3 expression in human atherosclerotic lesions","first-page":"152","author":"Natchtigal","year":"1998"},{"key":"10.1016\/j.semarthrit.2023.152357_bib0014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0003319718780772","article-title":"Plasma galectin-3 and sonographic measures of carotid atherosclerosis in the atherosclerosis risk in communities study","volume":"70","author":"Oyenuga","year":"2019","journal-title":"Angiology"},{"key":"10.1016\/j.semarthrit.2023.152357_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12872-023-03310-y","article-title":"Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease","volume":"23","author":"Bo\u0161njak","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152357_bib0016","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/ATVBAHA.114.304964","article-title":"Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease","volume":"35","author":"Maiolino","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152357_bib0017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/clc.23105","article-title":"Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis","volume":"42","author":"Anyfanti","year":"2019","journal-title":"Clin Cardiol"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152357_bib0018","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152357_bib0019","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nuclcard.2007.10.009","article-title":"Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events","volume":"15","author":"Paulmier","year":"2008","journal-title":"J Nucl Cardiol"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152357_bib0020","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2967\/jnumed.109.065151","article-title":"18F-FDG PET\/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease","volume":"50","author":"Rominger","year":"2009","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152357_bib0021","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jacc.2013.04.066","article-title":"Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography\/computed tomography feasibility study","volume":"62","author":"Tawakol","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152357_bib0022","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/hrt.2005.080929","article-title":"Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial","volume":"92","author":"Houslay","year":"2006","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152357_bib0023","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/art.40345","article-title":"Arterial inflammation detected with (18) F-fluorodeoxyglucose-positron emission tomography in rheumatoid arthritis","volume":"70","author":"Geraldino-Pardilla","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152357_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007495","article-title":"Myocardial microvascular dysfunction in rheumatoid arthritis(quantitation by (13)N-ammonia positron emission tomography\/computed tomography)","volume":"12","author":"Amigues","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152357_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.39419","article-title":"Association of elevations of specific T cell and monocyte subpopulations in rheumatoid arthritis with subclinical coronary artery atherosclerosis","volume":"68","author":"Winchester","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152357_bib0026","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/acr.23106","article-title":"Association of anti-citrullinated peptide antibodies with coronary artery calcification in rheumatoid arthritis","volume":"69","author":"Geraldino-Pardilla","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152357_bib0027","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/art.40771","article-title":"Myocardial inflammation, measured using 18-fluorodeoxyglucose positron emission tomography with computed tomography, is associated with disease activity in rheumatoid arthritis","volume":"71","author":"Amigues","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152357_bib0028","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152357_bib0029","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.2006.054205","article-title":"Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values","volume":"66","author":"Inoue","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152357_bib0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152357_bib0031","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"Wells","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152357_bib0032","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152357_bib0033","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jacc.2007.05.024","article-title":"(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials","volume":"50","author":"Rudd","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152357_bib0034","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2023.152357_bib0035","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.3389\/fimmu.2018.03057","article-title":"Clinical relevance of galectin-1 and galectin-3 in rheumatoid arthritis patients: differential regulation and correlation with disease activity","volume":"9","author":"Mendez-Huergo","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152357_bib0036","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/ard-2022-223302","article-title":"Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis","volume":"82","author":"Solomon","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152357_bib0037","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/039463201102400409","article-title":"Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome","volume":"24","author":"Falcone","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152357_bib0038","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jama.2013.282535","article-title":"Calcium density of coronary artery plaque and risk of incident cardiovascular events","volume":"311","author":"Criqui","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152357_bib0039","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0003319718780772","article-title":"Plasma galectin-3 and sonographic measures of carotid atherosclerosis in the atherosclerosis risk in communities study","volume":"70","author":"Oyenuga","year":"2018","journal-title":"Angiology"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152357_bib0040","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2020.07.044","article-title":"Sex-specific associations of cardiovascular risk factors and biomarkers with incident heart failure","volume":"76","author":"Suthahar","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152357_bib0041","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003079","article-title":"Galectin-3 and risk of heart failure and death in blacks and whites","volume":"5","author":"McEvoy","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152357_bib0042","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.24574","article-title":"Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways","volume":"60","author":"Filer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152357_bib0043","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fmicb.2019.00185","article-title":"Galectin-3 deficiency facilitates TNF-\u03b1-dependent hepatocyte death and liver inflammation in MCMV infection","volume":"10","author":"Stojanovic","year":"2019","journal-title":"Front Microbiol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:13:34Z","timestamp":1758734014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017223001993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":43,"alternative-id":["S0049017223001993"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152357","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of galectin-3 levels with measures of vascular disease in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152357"}}